Dylan reacts to the results from the Pro Tour, and discusses how to apply what has been learned to the trading floor.
Blood Moon
Melira-Pod is a staple of the Modern format, so understanding it is crucial whether you decide to play with it or against it. Conner walks through the card choices and discusses how and when to sideboard with this complex combo deck.
David Schumann discusses the difference between hype-based spikes and price corrections, and how it should inform your decision to sell.
Jason Alt looks at the out-of-control hype that followed close on the heals of the PT, the Pro Tour itself, and results from SCG St. Louis.
Danny reflects on his impressions of the Pro Tour, and what speculative moves can be made in Modern moving forward.
We might have seen a record number of 100%+ gainers last week thanks to Pro Tour Valencia. Sigmund looks at which price jumps will stick and which are destined to retrace back down.
Dylan analyzes the major players in Modern, picking which cards gained and lost value with the recent changes to the format.
MTGO Player of the Year Paul Nemeth has a Bitterblossom Brew that’s neither Faeries nor B/x Tokens, yet can still kill an opponent out of nowhere. Could this be the new home of the recently unbanned Enchantment?
Several months in advance of the Modern season, prices are already moving on MTGO. Sylvain Lehoux looks at the state of Modern in light of data from past years.
Ryan details his choices for Standard and Legacy as the Invitational approaches.
Ryan gives a tournament report for a local Legacy event he recently did well at with RUG.
The full contents of Commander 2013 have been revealed. David Schumann looks at notable cards that may make an impact in Legacy.
This week Jason Alt questions the ancient maxim “better lucky than good” and dissects results from the first week of new Standard.
